Uploaded March 2025 | Updated September 2026, 1 day ago

---

A Northwestern Medicine study published in Nature Medicine used a new technique called spatial transcriptomics to examine the brain’s response to Alzheimer's therapies, revealing new molecular targets that could enhance the effectiveness of current therapies and not just slow the disease, but potentially improve patient outcomes.

David Gate, PhD, assistant professor of Neurology in the Ken and Ruth Davee Department of Neurology and director of the Abrams Research Center on Neurogenomics, led this research.

#alzheimers #alzheimersdisease #alzheimersresearch
-----------------------------------------

Visit the Feinberg website: https://www.feinberg.northwestern.edu/

SUBSCRIBE: spr.ly/60073dxlv

TWITTER (X): spr.ly/60003dxmj
INSTAGRAM: spr.ly/60083dxWi
FACEBOOK: spr.ly/60063dxW0
LINKEDIN: spr.ly/60063dxqG

About Northwestern University Feinberg School of Medicine in Chicago, Illinois:
Our mission is to impact the practice of medicine through discovery and education to improve human health.